Dr. Peter Attia

So let me ask a silly question. Why do you publish the results of the cloning before you've gone and made the recombinant protein yourself?

So let me ask a silly question. Why do you publish the results of the cloning before you've gone and made the recombinant protein yourself?

Okay. So once it's published after the patent, you get to make it.

Okay. So once it's published after the patent, you get to make it.

Was that known only once you started developing and you understood the kinetics of it?

Was that known only once you started developing and you understood the kinetics of it?

Yeah, so you can't give it prophylactically because you don't know who's going to get thrombocytopenia.

Yeah, so you can't give it prophylactically because you don't know who's going to get thrombocytopenia.

What do you do? You plasmapherese the patients if you've overshot? Or not plasmapherese, platelet-pherese.

What do you do? You plasmapherese the patients if you've overshot? Or not plasmapherese, platelet-pherese.

Tell folks how that drug worked, what it was for.

Tell folks how that drug worked, what it was for.

Why do you mechanistically, do you think that the overexpression of HER2 was impeding immune clearance? What was the thesis at the time for why overexpression of HER2 was cutting life expectancy down?

Why do you mechanistically, do you think that the overexpression of HER2 was impeding immune clearance? What was the thesis at the time for why overexpression of HER2 was cutting life expectancy down?

Of course, yeah.

Of course, yeah.

Yeah, but I think what I really enjoy about this type of discussion though, Sue, is one, it's the story of your career, but it's also the story of oncology.

Yeah, but I think what I really enjoy about this type of discussion though, Sue, is one, it's the story of your career, but it's also the story of oncology.

It's the story of modern oncology. So you're one of the few people whose careers takes us through the walk of modern oncology.

It's the story of modern oncology. So you're one of the few people whose careers takes us through the walk of modern oncology.